Life Sciences
AnalytiXIN is spearheading a groundbreaking initiative to unite healthcare organizations, clinical researchers, and life sciences innovators across Indiana.
This platform is built on collaboration, harnessing the strengths of organizations like Lilly, the Indiana University School of Medicine, Indiana University Health, the Indiana Biobank, and the Indiana Health Information Exchange. Together, we are driving forward disease-specific research and transformative clinical trials.
Our data asset powers both disease-specific and agnostic research to transform healthcare outcomes.
We strive to ensure clinical trials include diverse populations, addressing health disparities across Indiana.
By merging clinical and genomic data, we have the potential to extract profound insights to revolutionize patient care.
We are attracting top-tier talent and positioning Indiana as a leader in healthcare innovation.
We’re building a large database of health information that helps doctors and researchers find better ways to treat diseases.
$16M has already been invested through public and private partnerships to drive healthcare improvements for people living in Indiana.
Thousands of patients have already joined the project! With their help, we’re growing faster than many other clinical-genomic databases, putting Indiana on the map for destination medicine.
Our data includes health records that go back 30+ years, which helps researchers find patterns to improve medicine and treatments for the best outcomes for patients.
In the News
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud.
